| Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project KR Carson, AM Evens, EA Richey, TM Habermann, D Focosi, JF Seymour, ... Blood, The Journal of the American Society of Hematology 113 (20), 4834-4840, 2009 | 1049 | 2009 |
| An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era Z Zhou, LH Sehn, AW Rademaker, LI Gordon, AS LaCasce, ... Blood, The Journal of the American Society of Hematology 123 (6), 837-842, 2014 | 973 | 2014 |
| Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results … P Armand, A Nagler, EA Weller, SM Devine, DE Avigan, YB Chen, ... Journal of clinical oncology 31 (33), 4199, 2013 | 553 | 2013 |
| ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma RM Meyer, MK Gospodarowicz, JM Connors, RG Pearcey, WA Wells, ... New England Journal of Medicine 366 (5), 399-408, 2012 | 510 | 2012 |
| Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma PJ Stiff, JM Unger, JR Cook, LS Constine, S Couban, DA Stewart, ... New England Journal of Medicine 369 (18), 1681-1690, 2013 | 404 | 2013 |
| Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large … C Visco, Y Li, ZY Xu-Monette, RN Miranda, TM Green, A Tzankov, W Wen, ... Leukemia 26 (9), 2103-2113, 2012 | 401 | 2012 |
| Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP … ZY Xu-Monette, L Wu, C Visco, YC Tai, A Tzankov, W Liu, ... Blood, The Journal of the American Society of Hematology 120 (19), 3986-3996, 2012 | 392 | 2012 |
| Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study JN Winter, EA Weller, SJ Horning, M Krajewska, D Variakojis, ... Blood 107 (11), 4207-4213, 2006 | 366 | 2006 |
| Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a … A Advani, B Coiffier, MS Czuczman, M Dreyling, J Foran, E Gine, ... Journal of Clinical Oncology 28 (12), 2085-2093, 2010 | 346 | 2010 |
| Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era AM Evens, KA David, I Helenowski, B Nelson, D Kaufman, SM Kircher, ... Journal of Clinical Oncology 28 (6), 1038, 2010 | 346 | 2010 |
| Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression ED Jacobsen, JP Sharman, Y Oki, RH Advani, JN Winter, CM Bello, ... Blood, The Journal of the American Society of Hematology 125 (9), 1394-1402, 2015 | 315 | 2015 |
| Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. AL Epstein, RJ Marder, JN Winter, RI Fox Journal of immunology (Baltimore, Md.: 1950) 133 (2), 1028-1036, 1984 | 295 | 1984 |
| CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL … S Hu, ZY Xu-Monette, A Balasubramanyam, GC Manyam, C Visco, ... Blood, The Journal of the American Society of Hematology 121 (14), 2715-2724, 2013 | 280 | 2013 |
| Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma SJ Schuster, SS Neelapu, BL Gause, JE Janik, FM Muggia, ... Journal of clinical oncology 29 (20), 2787, 2011 | 278 | 2011 |
| Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole S Trifilio, S Singhal, S Williams, O Frankfurt, L Gordon, A Evens, J Winter, ... Bone marrow transplantation 40 (5), 451-456, 2007 | 255 | 2007 |
| Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients S Trifilio, G Pennick, J Pi, J Zook, M Golf, K Kaniecki, S Singhal, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 234 | 2007 |
| Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential AL Epstein, RJ Marder, JN Winter, E Stathopoulos, FM Chen, JW Parker, ... Cancer Research 47 (3), 830-840, 1987 | 211 | 1987 |
| Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International … C Visco, A Tzankov, ZY Xu-Monette, RN Miranda, YC Tai, Y Li, W Liu, ... Haematologica 98 (2), 255, 2013 | 195 | 2013 |
| t (3; 21)(q26; q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia CM Rubin, RA Larson, J Anastasi, JN Winter, M Thangavelu, ... | 194 | 1990 |
| Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma: report of the pivotal phase 2 study MA Rodriguez, R Pytlik, T Kozak, M Chhanabhai, R Gascoyne, B Lu, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 190 | 2009 |
